Tumor Microenvironment-Responsive Nanoparticles: Promising Cancer PTT Carriers
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Responsive nanomedicines targeting the tumor microenvironment (TME) offer new cancer treatment strategies. Combining TME-responsive nanomedicines with photothermal therapy (PTT) shows promise for overcoming drug resistance and improving patient outcomes.
Area Of Science
- Oncology
- Nanomedicine
- Biomedical Engineering
Background
- The tumor microenvironment (TME) presents unique challenges including hypoxia, low pH, and enzyme overexpression.
- These TME characteristics promote tumor growth, metastasis, and drug resistance, limiting conventional therapies.
- The TME's distinct features also present opportunities for targeted nanomedicine interventions.
Purpose Of The Study
- To review the predominant features of the TME.
- To explore recent advancements in TME-responsive nanomedicines for cancer therapy.
- To evaluate the potential of these nanomedicines in combination with photothermal therapy (PTT) and chemotherapy.
Main Methods
- Literature review of TME characteristics.
- Analysis of nanomedicine strategies targeting the TME.
- Evaluation of TME-responsive nanomedicines for combined PTT and chemotherapy.
Main Results
- TME-responsive nanomedicines can be designed to exploit specific tumor microenvironment features.
- Combination therapy using TME-responsive nanomedicines with PTT and chemotherapy demonstrates potential for multimodal antitumor effects.
- These approaches may overcome limitations of traditional cancer treatments.
Conclusions
- TME-responsive nanomedicines hold significant promise for enhancing cancer treatment efficacy.
- The integration of nanomedicine with PTT offers a viable strategy for multimodal cancer therapy.
- Further research into TME-responsive nanomaterials is crucial for clinical translation and improved patient outcomes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.